Navigation Links
VIDEO: Cancer Treatment Centers of America Selects Site in GA for Proposed Hospital Serving Patients in Southeast
Date:6/18/2009

All-digital Georgia facility to offer new choice in cancer treatment with fully integrated, individualized care model

CHICAGO, June 18 /PRNewswire/ -- Cancer Treatment Centers of America (CTCA) announced today that it has selected Newnan, Ga., as the site of a proposed cancer treatment hospital that will serve patients in the Southeast and provide 500 new jobs in metro Atlanta.

To View the Multimedia News Release, go to: http://www.prnewswire.com/mnr/cancercenter/38837

(Photo: http://www.newscom.com/cgi-bin/prnh/20090618/NY34895 )

"I'm excited that CTCA will now be closer to home," said Valerie Yurchuk, a cancer patient who treated at CTCA. "I could have gone to any cancer treatment program in the nation, but I came to CTCA because of its unique, patient-centered approach."

CTCA President and CEO Steve Bonner said the company chose Georgia as a gateway to better serve cancer patients throughout the Southeast.

"We are pleased to propose a new cancer treatment facility in the Southeast and thrilled to select Coweta County, one of the most sought-after destinations in metro Atlanta and Georgia," said Bonner. "Cancer patients living in the Southeast will have easier access to the high-quality, individualized, comprehensive care for which CTCA is known."

CTCA expects the new facility to generate $500 million in economic activity over the first five years of operation. With more than two-thirds of its patients expected to come from outside the state of Georgia, patients and their families will contribute to the growth and vitality of the local economy. The proposed fully digital Georgia facility will mark the fifth CTCA hospital to offer cancer patients a fully integrated care model, which combines the best traditional medical care to treat the cancer with scientifically supported integrative therapies to help manage side effects, strengthen the immune system and improve each person's quality of life.

The company will now file a notice of intent to apply for a certificate of need with the Georgia Department of Community Health (DCH), whose approval is necessary before CTCA can build and operate the facility. The Georgia hospital, if approved by DCH, will have 50 inpatient beds and more than 200,000 square feet.

"We're pleased to have CTCA here in Coweta County," said Bill Harrison, of the economic development authority. "They'll provide much-needed new jobs - and bring a vitally important service as well as hundreds of patients and family members to our region."

But more importantly, said Yurchuk, is proximity to the comprehensive care CTCA provides.

"CTCA didn't look at treating just my cancer, but looked at me as a whole person," she said. "My treatment plan was based on my individual needs. Everything was explained to me and I was the one making the decisions. That's the difference at CTCA - I was at the center of my care, from the very beginning."

About Cancer Treatment Centers of America

Cancer Treatment Centers of America (CTCA) is a national network of hospitals providing a comprehensive, fully integrative approach to cancer treatment. CTCA serves patients with advanced cancer from all 50 states at facilities located in suburban Chicago, Philadelphia, Tulsa and suburban Phoenix. For more information about Cancer Treatment Centers of America, go to cancercenter.com.


'/>"/>
SOURCE Cancer Treatment Centers of America
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Video: Nutrition Comes to NASCAR
2. Video: Circulatory Care of New Jersey
3. Video: GEN Video Hits Home with Web Audience
4. Video: Beyond the Red Door: Gildas Club Worldwide and DKNY Host Successful Benefit Event
5. Video: Food Expert B. Smith to Provide Healthy Menu Makeovers
6. Video: New FDA-Approved Sun Protectant Saves Skin All Year Round
7. Video: Kyphon Supports World Osteoporosis Day on October 20, 2007 to Raise Awareness of Osteoporosis and Spinal Fracture Risk
8. Video: Trinity Mother Frances Neurosurgeon First in Region to Remove Brain Tumor Using Unique Surgical Procedure
9. Video: Holiday Safety Is Important
10. Video: Grin Big With an Award-Winning Smile
11. Video: BSP Pharma Inc. Announces Groundbreaking Findings from The Australian Centre for Complementary Medicine Education and Research Joint Health Clinical Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... ... 24, 2017 , ... HealthPostures, expert standing desk solution designer, ... built into the home office sit stand solution are bold colors, a new ... the benefits embedded in the TaskMate Go are available 24/7 through HealthPostures' online ...
(Date:2/24/2017)... ... February 24, 2017 , ... Only two months after the official release of ... in Cannes (France), XO Private has initiated a second print-run of its lavish luxury ... a metre across when open, weighs in at more than six kilos, retails at ...
(Date:2/24/2017)... ... 2017 , ... An in-depth computational analysis of genetic variants implicated in both ... genes that may explain why susceptibility to one of the disorders could place individuals ... today in the journal npj Schizophrenia. , “There is a wealth of genomic ...
(Date:2/24/2017)... ... ... The Smart Machine Age is here, and it’s disrupting everything. Not only ... jobs in the United States may be taken over by technology in the next ... who steamrolls over colleagues is drawing to a close. Success will belong to those ...
(Date:2/24/2017)... ... February 24, 2017 , ... ... disabilities, it is so critically important that we all are aware of our ... why Mediaplanet is proud to announce the launch of its newest edition of ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... BRISBANE, Australia , Feb. 23, 2017  Directors from Pharma ... the two companies have joined forces, resulting in the founding of ... . Pharma To Market are pleased to announce their ... an office in Singapore . The company are ... Consulting as Co-Director of the Singapore based ...
(Date:2/24/2017)... -- Xynomic Pharmaceuticals, Inc., an oncology drug research and ... exclusive worldwide rights to develop, manufacture and commercialize ... hematological and solid tumors. To date ... clinical trials of Abexinostat in US, EU and ... completed, demonstrating that Abexinostat is clinically active in ...
(Date:2/23/2017)... Februar 2017 LG Innotek hat heute die ... Sterilisationsleistung beträgt das 1,5-fache des 45-mW-Moduls der Konkurrenz. ... zwischen 200 und 280 nm und eignet sich damit für ... ihre DNA zerstört. Das Produkt von LG Innotek erzeugt ... ...
Breaking Medicine Technology: